Therapeutic outcome raloxifene (Evista) Ans- decreases bone reabsorption; slows down bone loss and
preserves mineral density in postmenopausal osteoporosis
Also used to protect again breast cancer
Penicillin adverse effects: Ans- Allergies/anaphylaxis , renal impairment
Macrolide Prototype Drug Ans- erythromycin (e-mycin)
Airflow Disorders: Teaching About Theophylline Ans- If dysrhythmias or seizure occur, stop medication.
Periodic blood levels are needed.
Report nausea, diarrhea, or restlessness.
Avoid consuming caffeinated beverages.
digoxin toxicity symptoms Ans- fatigue, weakness, vision changes, GI effects
digoxin level Ans- 0.5 to 2.0 ng/mL
How to give digoxin Ans- infuse over at least 5 min, and monitor client for dysrhythmias.
Management of digoxin toxicity Ans- Digoxin and potassium-sparing medication should be stopped
immediately.
Monitor K+ levels. For levels less than 3.5 mEq/L, administer potassium IV or by mouth. Do not
give any further K+ if the level is greater than 5.0 mEq/L.
Treat dysrhythmias with phenytoin (Dilantin) or lidocaine.
, Treat bradycardia with atropine.
For excessive overdose, activated charcoal, cholestyramine, or Digibind can be used to bind digoxin and
prevent absorption
How to Treat dysrhythmias for digoxin toxicity patients Ans- Phenytoin
Lidocaine
Cyclophosphamide Alkylating agent (nitrogen mustard)
Adverse effects: Ans- Bone marrow suppression
Gi discomfort (N/V)
Acute hemorrhagic cystitis > monitor for hematuria, mesna can be given
Alopecia
Cyclophosphamide interactions Ans- Succinylcholine > increased neuromuscular blockade
Tricyclic Antidepressants Adverse Reactions Ans- -Orthostatic hypotension
-Anticholinergic effects
-Sedation
-Toxicity
-Decrease seizure threshold
-Excessive sweating
controlled substances Ans- Each level has a decreasing risk of abuse & dependence. For example,
morphine (Duramorph) is a schedule II medication that has greater risk of abuse & dependence than
phenobarbital (Luminal), which is a Schedule IV medication